Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
In a study conducted by Ng et
After the initial Phase III studies showed the GLP-1/GIP agonists effectively lowered hemoglobin A1c levels, several influential randomized trials were published investigating their effects on cardiovascular outcomes in diabetic patients
4.0 Future therapeutic opportunities in neurodegenerative diseases Recent clinical and preclinical evidence has established the potential of incretin mimetics to target pathological features central to neurodegenerative disorders
[PDF] nature.com Chen, Junjie, et al
US$ 21.33
US$ 24.48
US$ 25.90
US$ 29.07
US$ 22.72
US$ 22.05
US$ 23.71
US$ 29.92
